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Abstract
Background: Salivary rinses have been recently proposed as a valuable resource for the development of epigenetic
biomarkers for detection and monitoring of head and neck squamous cell carcinoma (HNSCC). Both salivary rinses collected
with and without an exfoliating brush from patients with HNSCC are used in detection of promoter hypermethylation, yet
their correlation of promoter hypermethylation has not been evaluated. This study was to evaluate the concordance of
promoter hypermethylation between salivary rinses collected with and without an exfoliating brush from patients with
HNSCC.
Methodolgy: 57 paired salivary rinses collected with or without an exfoliating brush from identical HNSCC patients were
evaluated for promoter hypermethylation status using Quantitative Methylation-Specific PCR. Target tumor suppressor
gene promoter regions were selected based on our previous studies describing a panel for HNSCC screening and
surveillance, including P16, CCNA1, DCC, TIMP3, MGMT, DAPK and MINT31.
Principal Findings: In salivary rinses collected with and without brush, frequent methylation was detected in P16 (8.8% vs.
5.2%), CCNA1 (26.3% vs. 22.8%), DCC (33.3% vs. 29.8%), TIMP3 (31.6% vs. 36.8%), MGMT (29.8% vs. 38.6%), DAPK (14.0% vs.
19.2%), and MINT31 (10.5% vs. 8.8%). Spearman’s rank correlation coefficient showed a positive correlation between salivary
rinses collected with and without brush for P16 (r=0.79), CCNA1 (r=0.61), DCC (r=0.58), TIMP3 (r=0.10), MGMT (r=0.70),
DAPK (r=0.51) and MINT31 (r=0.72) (P,0.01). The percent agreement of promoter methylation between salivary rinses
with brush and without brush were 96.5% for P16, 82.5% for CCNA1, 78.9% for DCC, 59.7% for TIMP3, 84.2% for MGMT, 84.2%
for DAPK, and 94.7% for MINT31.
Conclusions: Our study demonstrated strong correlations of gene promoter hypermethylation between salivary rinses
collected with and without an exfoliating brush. Salivary rinse collection without using an exfoliating brush may offer a cost
effective, rapid, non-invasive, and reliable means for development of epigenetic salivary rinse biomarkers.
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Introduction
Head and neck squamous cell carcinoma (HNSCC) is the sixth most
common cancer in the world. More than 40,000 new cases of HNSCC
are diagnosed in the United States each year, with a mortality rate of
12,000 U.S. deaths annually. The etiology of HNSCC includes well-
known risk factors, such as tobacco smoking and alcohol drinking, as
well as infection of human papillomavirus (HPV) [1,2]. Despite
significant improvements in therapeutic modalities, 5-year survival
rates are still among the lowest of the major cancers, with loco-regional
r e l a p s eb e i n gt h ep r i m a r yc a u s eo fd e a t h .
Saliva is a readily obtained body fluid that contains cells shed
from the mucosal lining of the mouth and throat. It is becoming a
promising diagnostic tool for non-invasive and cost effective
HNSCC detection. As a type of body fluid, saliva can potentially
carry whole cells as well as protein, RNA, and DNA species that
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Salivary proteome analyses for oral cancer has been reported and
a number of specific genes and proteins have been proposed as
biomarkers for clinical diagnosis, including p53, Cyfra21-1 tissue
polypeptide antigen and CD44 [3,4,5,6,7]. Studies have demon-
strated that thousands of cell-free mRNAs and miRNAs are
present in saliva and demonstrated the feasibility of using salivary
mRNAs/miRNAs for detection of oral cancer [8,9,10]. The
inactivation of tumor suppressor genes caused by epigenetic
changes such as promoter region CpG island hypermethylation
has been well established in the literature. Aberrant promoter
hypermethylation of cancer-associated genes are common in many
human cancers including HNSCC [11]. The detection of gene
promoter hypermethylation in salivary rinses has been explored as
a potential for diagnostic and monitoring of HNSCC
[12,13,14,15]. We have previously published results of salivary
rinse screening using promoter hypermethylation-based markers
in patients with previously diagnosed HNSCC. Our group has
developed a panel for detection of HNSCC by evaluation of
salivary rinses from these patients. For the initial screening of 21
genes for salivary rinses, ultimately seven genes (P16, CCNA1,
DCC, TIMP3, MGMT, DAPK, and MINT31) were selected as part
of a panel to distinguish salivary rinses from HNSCC patients and
healthy controls [16]. Moreover, we found detection of hyper-
methylation in pre-treatment salivary rinse DNA appears to be
predictive of local recurrence and overall survival [17].
Clinically, salivary rinses can be obtained by brushing oral cavity
and oropharyngeal surfaces with an exfoliating brush followed by
rinse and gargle. The tissue collected using this technique includes
exfoliated epithelial cells from the upper aerodigestive tract, and an
exfoliating brush is used to include cells from deep epithelial layers
in the oral cavity and oropharynx [12,16]. This technique allows for
a broad sampling of epithelial cells from multiple sites in the upper
aerodigestive tract. Alternatively, salivary rinses can be obtained
without using an exfoliating brush [18]. To date, salivary rinses
collected with and without an exfoliating brush from patients with
HNSCC have been widely used in the development of epigenetic
biomarkers. However, the correlation of gene promoter hyper-
methylation between salivary rinses collected with and without an
exfoliating brush has not yet been studied.
The ability to detect molecular alterations in salivary rinses has
been proposed as a potential low-cost method to detect individuals
at risk for head and neck cancer development, and as a potential
surveillance tool for HNSC patients. However, use of an
exfoliating brush to obtain material in salivary rinses requires
administration by a trained health care provider, as well as use of
specific, exfoliating brushes with potential added expense. The
demonstration that adequate harvest of aberrant, methylated
DNA can occur with a less intensive technique that may
potentially be performed independently by patients without the
need for specialized equipment would make salivary based
detection more easily adoptable and more cost effective. In this
study, we compared the patterns of promoter hypermethylation in
salivary rinses collected with and without brush from patients with
HNSCC. We show that salivary rinses collected with and without
brush share similar hypermethylation patterns, suggesting that
brush use may not be necessary to harvest salivary rinses for the
study of DNA hypermethylation in patients with HNSCC.
Materials and Methods
Subjects
All human oral salivary rinse samples were obtained and used
according to the policies of the Johns Hopkins Medical Institutions.
The experimental protocol was approved by the Johns Hopkins
Medical Institutions Review Board. Witten informed consent was
obtained from each subject prior to the use of their tissue for
scientific research. Between June 2005 and Oct 2010, the salivary
rinse samples were prospectively collected with an exfoliated brush
from patients (n=197) presenting a previously untreated squamous
cell carcinoma from the oral cavity, larynx, or pharynx, at the
Department of Otolaryngology-Head and Neck Surgery, Johns
Hopkins Medical Institutions (Baltimore, MD). Among the 197
patients, 57 pairedsalivary rinsesampleswere alsocollected without
using an exfoliating brush. In our salivary rinse collection, no
selection criteria were applied on patients. To obtain clinical
information, we reviewed medical records to identify patients with
pathologically confirmed HNSCC. Enrollment included collection
of demographic information and risk factor history (tobacco and
alcohol). Smoking was defined as use of tobacco, chewable or
smoked, for at least 1 year continuously. Alcohol use was defined as
intake of more than two alcoholic drinks per day.
Collection of salivary rinse samples
Salivary rinses were obtained from all subjects as previously
described [16,18,19]. Pretreatment salivary rinse samples were
collected before tumor resection on the day of tumor resection.
Patients firstly contributed a pretreatment oral rinse by swishing
and gargling for 15 s with 20 ml of normal saline solution followed
by expectoration (salivary rinse collected without brush). Then an
exfoliating brush was used to brush oral cavity and oropharyngeal
surfaces followed by rinse and gargling with 20 ml normal saline
solution (salivary rinse collected with brush). The tumor site was
intentionally avoided during brushing. This technique allows for a
broad sampling of epithelial cells from multiple sites in the upper
aerodigestive tract. The brush was gently agitated to release the
obtained material into saline. After centrifugation, the supernatant
was discarded and DNA was isolated from the pellet. The method
with brush obviously generates more DNAs than the method
without brush.
DNA extraction
DNA obtained from salivary rinse samples was extracted by the
tissue bank by digestion with 50 mg/mL proteinase K (Boehringer)
in the presence of 1% SDS at 48uC overnight followed by phenol/
chloroform extraction and ethanol precipitation.
Bisulfite treatment
The DNA obtained from the salivary rinse samples was
subjected to bisulfite treatment, using the EpiTect Bisulfite kit
from Qiagen according to the manufacturer’s conditions, http://
www.Qiagen.com. Bifulfite-treated DNA was eluted in 30 mLo f
elution buffer and stored at 280uC [17,20].
Quantitative methylation-specific PCR
The bisulfite-treated DNA was used as a template for
fluorescence-based real-time Q-MSP as described previously
[21]. The P16, CCNA1, DCC, TIMP3, MGMT, DAPK, MINT31
and ACTB genes had been previously detected on a prior screen
of salivary rinses in HNSCC patients [16,17]. We had optimized
the primer and probe sequences for Q-MSP, and their sequences
are published previously [16]. The ratios between the values of the
gene of interest and the reference gene ACTB were obtained by
TaqMan analysis and used as a measure for representing the
relative quantity of methylation in a particular sample (value for
gene of interest/value for ACTB gene6100). Fluorogenic PCRs
were carried out in a reaction volume of 10 mL of 200 nmol/L of
Methylation in Salivary Rinses with/without Brush
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Polymerase (Invitrogen), 100 mmol/L of ROX Reference Dye
(Invitrogen), 8.4 mmol/L ammonium sulfate, 33.5 mmol/L
Trizma (Sigma), 3.35 mmol/L magnesium chloride, 5 mmol/L
mercaptoethanol, and 0.05% DMSO. Each real-time Q-MSP
reaction consisted of 1.5 mL of treated DNA solution. Amplifica-
tions were carried out in 384-well plates in a 7900 Sequence
Detector System (Perkin-Elmer Applied Biosystems). Thermal
cycling was initiated with a first denaturation step at 95uC for
2 minutes followed by 50 cycles of 95uC for 15 seconds and 60uC
for 1 minute. Each reaction was done in triplicate; the average of
the triplicate was considered for analysis. The triplicate reactions
also provided evidence of reproducibility of the individual reactions.
Standardization was done by collecting leukocytes from a healthy
individual and subjecting the cellstomethylationinvitrowith excess
SssI methyltransferase (New England Biolabs) to generate com-
pletely methylated DNA, and serial dilutions (45-0.0045 ng) of this
DNA were used to construct a calibration curve for each plate [22].
The DNA was then bisulfite treated as described above. Serial
dilutions of the DNA were used for constructing the calibration
curvesoneachplate.A separate sampleofleukocytesfrom a healthy
individual was obtained and only bisulfite treatment was done on
the samples. These samples were used as a negative control for the
reactions. There were also several control wells in each plate that
contained only the reaction mix and water to ensure that there was
no contamination. The results of Q-MSP were analyzed by
considering the quantity of mehylation normalized by ACTB as
well as the quantity of methylation as a binary event, in which any
quantity ofmethylation ina samplewould be considered positivefor
methyaltion.
Target gene selection
Genes selected for this study came from a study to develop a
panel for HNSCC detection and surveillance in body fluids
[16,17]. These genes included P16, CCNA1, DCC, TIMP3,
MGMT, DAPK, and MINT31.
HPV analysis
The HPV status was determined as described previously
[17,23]. In brief, specific primers and probes have been designed
to amplify the E6, E7 regions of HPV16. Their sequences are
available in previous publications [17,23]. All the samples were
run in duplicate. Primers and probes to a house keeping gene (b-
actin) were run in duplicate and parallel to normalize input DNA.
Samples in which two results were not concordant were repeated
twice in duplicate and were usually due to failed PCR in one of the
initial reactions. Each reaction was run for 50 cycles. By using
serial dilutions, standard curves were developed for the HPV 16
viral copy number using CaSki (American Type Culture
Collection, Manassas, VA) cell line genomic DNA, known to
have 600 copies/genome (6.6 pg of DNA/genome). Standard
curves were developed for HPV16 E6 and E7, using serial
dilutions of DNA extracted from CaSki cells with 50,000 pg,
5,000 pg, 500 pg, 50 pg and 5 pg of DNA. Standard curves were
developed as well for the b-actin housekeeping gene (2 copies/
genome), using the same serial dilutions of the CaSki genomic
DNA. This additional step allowed for relative quantification of
the input DNA level and final quantity as the number of viral
copies/genome/cell. HPV copy number .0.1 copy/cell for tumor
samples were regarded as positive. For saliva samples, any
amplified sample with HPV E6 or E7 amplification at control b-
actin amplification of 10 ng was regarded as positive.
Statistical analysis
The promoter methylation of seven individual genes was
analyzed in two ways: as a continuous variable and as a binary
variable (methylation versus no methylation) by dichotomizing
each gene at zero. As a continuous variable, levels of promoter
methylation were summarized with scatter plots. For each of the
seven genes, the correlation of promoter methylation between
salivary rinses collected with and without an exfoliating brush was
determined by calculating a Spearman’s correlation coefficient. As
a binary variable (methylation versus no methylation), the
frequency of methylated and unmethylated cases for seven
individual genes were determined. For each of these genes, we
evaluate the agreement between the methods with and without
brush as the proportion of samples that is classified to the same
methylation status by them. Concordance was assessed by using
Cohen’s kappa (k), a coefficient of agreement that corrects for
chance [24]. Landis and Koch proposed categories for judging k
values: k less than 0.00 was poor, 0.00 to 0.20 was slight, 0.21 to
0.40 was fair, 0.41 to 0.60 was moderate, 0.61 to 0.80 was
substantial, and 0.81 to 1.00 was almost perfect [25]. Association
between methylation status of each studied gene and clinical and
pathologic variables in salivary rinse collected with or without an
exfoliating brush were analyzed by multivariate analysis using
logistic regression models. All statistical analyses were performed
in SAS (Cary, NC). All statistical tests were two sided. A p value
less than 0.05 would indicate statistical significance.
Results
1. Clinical and pathologic characteristics
Fifty-seven patients were included in this study (Table 1).
HNSCC Patients were mainly males (77.2%), Caucasians (93.0%)
with ages ranging from 29 to 87 years old (median, 56.5 years).
Alcohol or tobacco consumption (current or former) was reported
by 59.7% and 70.2%, respectively. HPV status was positive in 26
cases (45.6%). Primary tumor sites included: oral cavity, 22 cases
(38.6%); oropharynx, 30 (52.6%) and other, 5 (8.8%). Pathological
clinical stage at diagnosis was pT1/pT2 in 43 cases (75.5%), pT3/
pT4 in 11 (19.3%) and pTx in 3 (5.3%); pN0 in 16 cases (28.1%)
and pN+ in 41 (71.9%). With regard to clinical TNM
classification, 13 patients had stage I/II and 44 patients, stage
III/IV. This study intends to evaluate the relationship of the
methods of salivary rinse collection with and with exfoliating brush
to determine promoter hypermethylation in salivary rinses,
therefore we do not include patient outcomes. In this respect,
for salivary rinse samples collected with an exfoliating brush, we
recently published a prognostic analysis of these salivary rinse
methylation biomarkers [26].
2. Frequencies of promoter hypermethylation in salivary
rinses collected with and without an exfoliating brush
from 57 patients with HNSCC
We tested promoter methylation pattern of P16, CCNA1, DCC,
TIMP3, MGMT, DAPK,a n dMINT31 in 57 paired salivary rinses
that were collected with or without an exfoliating brush from the
above patients with HNSCC. These seven genes selected for this
studywerefrom ourpreviousstudiestodevelop a panelforHNSCC
detection and surveillance in salivary rinses. The methylation levels
of these selected genes in salivary rinses collected with or without an
exfoliating brush from HNSCC patients were shown in Figure S1.
In the salivary rinse samples collected with an exfoliating brush,
frequent methylation was detected in P16 (8.8%), CCNA1 (26.3%),
DCC (33.3%), TIMP3 (31.6%), MGMT (29.8%), DAPK (14.0%), and
MINT31 (10.5%) (Table 2). In the salivary rinse samples collected
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P16, 22.8% for CCNA1, 29.8% for DCC, 36.8% for TIMP3, 38.6%
for MGMT, 19.2% for DAPK, and 8.8% for MINT31 (Table 2).
Figure 1 summarized the methylation profiles of each of the seven
genes for the 57 pairs of salivary rinses collected with brush and
without brush from patient with HNSCC. Methylation genes had
been categorized as methylated for any value greater than zero.
3. Concordance of promoter methylation of the seven
individual genes in salivary rinses collected with and
without an exfoliating brush from 57 patients with
HNSCC
We analyzed the correlation of promoter methylation status of
these seven individual genes between salivary rinses collected with
brush and without brush by Spearman correlation analysis, using
methylation levels as a continuous variable (Table 2). We found
strong correlations between the salivaryrinses with brush and without
brush for P16 (r=0.79, P,0.0001), CCNA1 (r=0.61, P,0.0001),
DCC (r=0.58, P,0.0001), MGMT (r=0.70, P,0.0001), DAPK
(r=0.51, P,0.0001) and MINT31 (r=0.72, P,0.001).
We also assessed concordance of the promoter methylation status
ofthesesevenindividualgenesbetween salivaryrinsescollectedwith
and without an exfoliating brush using methylation levels as a
categorical variable. As shown in Table 3, the percent agreement
between the salivary rinseswith brush and without brushwas96.5%
for P16, 82.5% for CCNA1, 78.9% for DCC, 59.7% for TIMP3,
84.2% for MGMT, 84.2% for DAPK, and 94.7% for MINT31
(Table 3). Furthermore, we used Cohen’s kappa (k) to evaluate the
concordance of promoter methylation between salivary rinses
collected with and without an exfoliating brush. Of note, the kappa
statistic depends on the underlying methylation prevalence, which
may lead to smaller kappa even when the % agreement is higher
(Table 3). Overall, moderate agreements of promoter methylation
at CCNA1 (k=0.53), DCC (k=0.51), and DAPK (k=0.43) were
noted between salivary rinse with brush and without brush;
substantial agreements of promoter methylation at P16 (k=0.73),
MGMT (k=0.65), and MINT31 (k=0.70) were demonstrated
between salivary rinses with brush and without brush (Table 3).
4. Association of promoter methylation in salivary rinses
collected with brush or without brush with clinical and
pathologic characteristics
We determined the association of the promoter methylation of
each marker individually with the clinical and pathological
variables in HNSCC using multivariate logistic regression. The
clinical and pathological variables considered in the multivariate
analysis were age, gender, smoking status, HPV status, primary
tumor site, pathological tumor stage, pathological nodal stage and
clinical TNM stage. In the salivary rinse samples collected with
brush, smoking status was associated with promoter methylation of
TIMP3; HPV status was associated with promoter methylation of
CCNA1, DCC, and MGMT; primary tumor site (Oral cavity) was
associated with promoter methylation of CCNA1, DCC and DAPK;
clinical TNM stage were associated with promoter methylation of
P16, DCC, and MINT31; and pathological nodal stage was
associated with promoter methylation of P16 and MINT31 (Table
S1). In the salivary rinse samples collected without brush, primary
tumor site was associated promoter methylation of CCNA1; and
clinical TNM stage was associated with promoter methylation of
CCNA1 and DCC (Table S1). Due to our sample size, the
association between clinical and pathological characteristics and
gene promoter methylation should be interpreted with caution.
Discussion
Body fluids such as saliva are potential resources for
development of biomarkers for detection, diagnosis, and prognosis
Table 1. Baseline Characteristics of the Patients.
Characteristic No. of Patients %
Age at study entry
,55 yr 23 40.4%
55–64 yr 17 29.8%
.64 yr 17 29.8%
Mean(Year) 56.5
Range 29–87
Sex
Male 44 77.2%
Female 13 22.8%
Race
Caucasian 53 93.0%
African 3 5.3%
Asian 1 1.8%
Smoking status
Never Smoked 17 29.8%
Former 20 35.1%
Current 14 24.6%
Unknown 6 10.5%
Alcohol
Never Used 10 17.5%
Used 40 70.2%
Unknown 7 12.3%
HPV
Negative 31 54.4%
Positive 26 45.6%
Primary Site
Oral cavity 22 38.6%
Oropharynx 30 52.6%
Other 5 8.8%
Pathological tumor Stage
T1 27 47.4%
T2 16 28.1%
T3 5 8.8%
T4 6 10.5%
Tx 3 5.3%
Pathological nodal stage
N0 16 28.1%
N1 7 12.3%
N2 34 59.6%
Clinical TNM stage
I 10 17.5%
II 3 5.3%
III 7 12.3%
IV 37 64.9%
doi:10.1371/journal.pone.0033642.t001
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recently proposed as a means for detection of HNSCC in salivary
rinses. Recently, our group published the utility of evaluating the
promoter region methylation status of various genes as a tool for
detection of HNSCC. In our study, seven genes, comprised of
DAPK, DCC, MINT31, TIMP3, P16, MGMT and CCNA1, were
identified as part of a panel that could distinguish salivary rinses
from HNSCC patients and healthy controls [16]. With a pilot
cohort of 61 HNSCC patients, we also found that the detection of
these markers in pretreatment salivary rinse is a likely prognostic
indicator for local recurrence and poor survival [17].
Salivary rinses used for promoter hypermethylation assay in the
literature have been collected either with or without an exfoliating
brush [16,18]. An exfoliating brush could be used to include cells
from deep epithelial layers in the oral cavity and oropharynx. It
also allows for a broad sampling of epithelial cells from multiple
sites in the upper aerodigestive tract. Although both salivary rinses
collected with and without an exfoliating brush has been reported
in detection of promoter hypermethylation, the clinical signifi-
cance of exfoliating brush use in salivary rinse collection for
detection of promoter hypermethylation is unknown. There has
been no direct study of the correlation of promoter hypermethyla-
tion between salivary rinses collected with and without an
exfoliating brush.
In this study, we first determined the promoter methylation
pattern of seven individual genes, including P16, CCNA1, DCC,
TIMP3, MGMT, DAPK, and MINT31, in 57 paired salivary rinses
collected with or without an exfoliating brush from patients with
HNSCC, and then evaluated the concordance of promoter
hypermethylation between salivary rinses collected without brush
and those with brush. As shown in Table 1, the clinical and
pathological characteristics of these 57 patients with HNSCC
appeared comparable to the patient cohort we previously
published, and were broadly representative of standard clinical
practice. To circumvent the possible confounding factors that may
be involved in salivary rinse collection, we have collected each pair
of salivary rinses (with and without an exfoliating brush)
sequentially during one visit to the physician’s office. Quantitative
methylation-specific PCR was used to detect the promoter
hymermethylation in salivary rinse sample DNA. This real-time
PCR methodology allows a more objective, robust, and rapid
assessment of promoter methylation status. Give the sensitivity of
the QMSP technique used to detect the presence of methylated
alleles in a background of normal at a threshold of 1/1,000 to 1/
10,000, this strategy allowed us to define methylated genes that
were highly specific for tumor, and rarely or never present in any
of the aerodigestive sites that shed cells in salivary rinses.
We reported that promoter hypermethylation frequencies of
P16, CCNA1, DCC, MGMT, DAPK, and MINT31 could be
detected in salivary rinses collected without an exfoliating brush
at levels comparable to those in salivary rinses collected with
brush. We showed that the promoter hypermethylation frequen-
cies of these studied genes in salivary rinses collected with and
without an exfoliating brush were between 8.8% and 31.6% and
between 5.2% and 38.6%, respectively [16,17].
Our study also demonstrated a concordance of gene promoter
methylation between salivary rinses collected with an exfoliating
Table 2. Frequency of promoter methylation of the seven genes analyzed in the salivary rinses collected with or without an
exfoliating brush from 57 HNSCC patients, and Spearman correlation of promoter methylation levels.
Gene
Methylation Positive %
(no. of methylation positive/no. total
cases) Spearman’s Correlation
WB1 WOB{ Coefficient P value
P16 8.8 (5/57) 5.2 (3/57) 0.79 ,0.0001
CCNA1 26.3 (15/57) 22.8 (13/57) 0.61 ,0.0001
DCC 33.3 (19/57) 29.8 (17/57) 0.58 ,0.0001
TIMP3 31.6 (18/57) 36.8 (21/57) 0.10 0.49
MGMT 29.8 (17/57) 38.6 (22/57) 0.70 ,0.0001
DAPK 14.0 (8/57) 19.2 (11/57) 0.51 ,0.0001
MINT31 10.5 (6/57) 8.8 (7/57) 0.72 ,0.001
1WB=salivary rinses collected with an exfoliating brush.
{WOB=salivary rinses collected without a brush.
doi:10.1371/journal.pone.0033642.t002
Figure 1. Aberrant promoter methylation in the DNAs from
salivary rinses collected with or without an exfoliating brush
from 57 HNSCC cancer patients. Each column represents a patient,
and each row the methylation status of the given gene in salivary
samples collected with brush or without brush. Black shading indicates
promoter hypermethylation and white indicates lack of promoter
methylation. WB, salivary rinses collected with an exfoliating brush;
WOB, salivary rinses collected without brush.
doi:10.1371/journal.pone.0033642.g001
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study, Spearman rank analysis showed a strong correlation for
promoter hypermethylation of P16, CCNA1, DCC, MGMT, DAPK,
and MINT31, although a weak correlation for TIMP3 promoter
hypermethylation was found (The reason why TIMP3 was poorly
concordant was unknown.). We also found a strong agreement for
promoter hypermethylation of these markers (Table 3). Mean-
while, as revealed by Cohen’s kappa statistic, we found moderate
agreements of promoter methylation at CCNA1, DCC and DAPK
and substantial agreements of promoter methylation at P16,
MGMT and MINT31. It should be noted that the kappa statistic
also depends on the underlying methylation prevalence that may
lead may lead to smaller kappa even the percent agreement is
higher. In addition, the techniques we used for paired salivary
rinse collection may attenuate the concordances of gene promoter
methylation to some extent, making it seem like the techniques are
less agreeable than they actually are. We don’t exclude the
possibility that the initial salivary rinses without brushing capture
much of the loose epithelial and tumor cells whereas the rinses
with brushing capture fewer tumor cells, since there was already a
prior rinse. As an additional point, it remain to be investigated
whether detection of methylation markers from saliva more than
once will increase the total percentage of the positive cases, no
matter using brush or not.
The concordance of promoter hypermethylation between
salivary rinses collected with and without an exfoliating brush
may have biological implications. To date, the mechanism leading
to the presence of gene promoter hypermethylation in salivary
rinse is not well understood. It is likely that 1) aggressive tumors
may undergo increase rate of mechanical dissociation or shedding
into salivary rinses. Those tumor with a higher burden of
epigenetic alteration would be more frequently detected in salivary
rinses; 2) salivary rinse tumor DNA with epigenetic alterations
may also originate from cells that have left the primary site and
have invaded the circulatory system but are still not capable of
metastasis to new organ; 3) premalignant clonal patches expanded
will beyond primary tumor location, resulting a large surface area
of epigenetically altered cells to shed into the saliva [17,19].
Previous studies hypothesized that salivary rinses collected without
an exfoliating brush may not have enough oropharyngeal cells to
meet cutoffs for positive biomarker findings in case. Brushing,
which are site specific, may help overcome these obstacles [27].
However, based on our current study, at least for study of gene
promoter methylation in salivary rinses, detection of gene
promoter hypermethylation between salivary rinses collected with
and without an exfoliating brush is concordant, suggesting that an
exfoliating brush is not necessary to be used for salivary rinse
collection.
The concordance of promoter hypermethylation between
salivary rinses collected with and without an exfoliating brush
have potentially important clinical implications. In comparison to
collection of salivary rinses with an exfoliating brush for
development of epigenetic biomarkers for epigenetic study, there
are numerous potential advantages for the collection of salivary
rinses without using an exfoliating brush. For instance, the method
is non-invasive (the sample is relatively easy and painless to
Table 3. Concordance between salivary rinses collected with or without an exfoliating brush from 57 HNSCC patients.
Agreement Kappa 95% CI11
Genes WOB{ (2) WOB(+)( % )
P16
WB1 (2) 52 0 96.5 0.73 0.38–1
WB (+)2 3
CCNA1
WB (2) 38 4 82.5 0.53 0.27–78
WB (+)6 9
DCC
WB (2) 33 5 78.9 0.51 0.27–0.75
WB (+)7 1 2
TIMP3
WB (2) 26 13 59.7 0.11 20.16–0.37
WB (+)1 0 8
MGMT
WB (2) 33 7 84.2 0.65 0.45–0.86
WB (+)2 1 5
DAPK
WB (2) 43 6 84.2 0.43 0.13–0.74
WB (+)3 5
MINT31
WB (2) 50 1 94.7 0.70 0.38–1
WB (+)2 1 4
1WB=salivary rinses collected with an exfoliating brush.
{WOB=salivary rinses collected without a brush.
11CI=Confidence Interval.
doi:10.1371/journal.pone.0033642.t003
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brush), and lends itself to easy administration (it is likely patients
can perform this collection by themselves). Thus, the collection of
salivary rinses without using an exfoliating brush could be an
efficient, cost effective and reliable method for obtaining material
for detection of HNSCC related markers.
In summary, the present study compared the detection of
similar promoter hypermethylation frequencies of seven individual
genes between salivary rinses collected with and without an
exfoliating brush from patients with HNSCC. Moreover, our study
for the first time demonstrated a strong concordance of gene
promoter hypermethylation between salivary rinses collected with
and without brush. This study suggests that use of an exfoliating
brush may not be necessary for salivary rinse collection for the
detection of promoter hypermethylation biomarkers of HNSCC
detection.
Supporting Information
Figure S1 Promoter methylation levels for seven genes
(P16, CCNA1, DCC, TIMP3, MGMT, DAPK and MINT31)
in the DNAs from salivary rinses collected with and
without an exfoliating brush from 57 HNSCC cancer
patients. The quantity of methylated allele of each gene was
expressed as the ratio of the amount of polymerase chain reaction
products amplified from the methylated gene to the amount
amplified from the reference gene b actin multiplied by 100.
(TIF)
Table S1 Association of each marker in salivary rinses
collected with or without brush with selected features.
Association between methylation status of each studied gene and
clinical and pathologic variable in 57 salivary rinses collected with
or without an exfoliating bursh were analysed by multivariate
analysis using logistic regression models. Odds Ratios and 95%
Confidence Interval was shown in the table. Statistical Significance
was indicated as red.
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